Delivery Order SPE2DB25D3005-SPE2DB25FQDAW
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a ceiling value of $13,399.71 and an ultimate completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This is a $4,620.93 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a medication, with a period of performance through April 28, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULES in quantities of 30s, with a firm fixed-price ceiling value of $26,799.42. The contract has an ultimate completion date of November 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ZEPOSIA 0.92 MG CAPSULE 30S, a medication, with a ceiling value of $4,620.93 and a completion date of January 22, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a firm fixed price of $4,466.57 and a completion date of October 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a ceiling value of $13,862.79 and a performance period ending on August 5, 2025. The contract is not set-aside and represents an open competition. AmerisourceBergen Drug Corporation holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract is a firm-fixed price delivery order with a ceiling value of $13,862.79 and a period of performance ending on July 16, 2025. The contract is not a set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $13,862.79. It is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of July 10, 2025 and was awarded on June...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a ceiling value of $27,725.58 and a period of performance through July 21, 2025. The contract is not designated as a set-aside and appears to be open competition. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical product ZEPOSIA 0.92 MG CAPSULE 30S, with a ceiling value of $4,620.93 and an ultimate completion date of August 6, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQDAWDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a ceiling value of $4,620.93 and a period of performance through March 26, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 3/5/25 |